Exxua

Active Ingredient(s): Gepirone Hydrochloride
FDA Approved: * September 22, 2023
Pharm Company: * FABRE-KRAMER PHARMACEUTICALS, INC.
Category: Antidepressant

Gepirone is an antidepressant and anxiolytic drug of the azapirone group that was synthesized by Bristol-Myers Squibb in 1986 and has been under development for the treatment of depression but has yet to be marketed.[1][2][3] It has been under development in the U.S. in an extended release form (referred to as gepirone ER), but despite completing phase III clinical trials and demonstrating efficacy,[3] it has been rejected multip... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Exxua 18.2 mg Oral Tablet, Delayed Release
NDC: 83504-150
Labeler:
Fabre Kramer Pharmaceuticals, Inc.
Exxua 36.3 mg Oral Tablet, Delayed Release
NDC: 83504-151
Labeler:
Fabre Kramer Pharmaceuticals, Inc.
Exxua 54.5 mg Oral Tablet, Delayed Release
NDC: 83504-152
Labeler:
Fabre Kramer Pharmaceuticals, Inc.
Exxua 72.6 mg Oral Tablet, Delayed Release
NDC: 83504-153
Labeler:
Fabre Kramer Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients